ELINA SCHWARTZ: Open Payments
NPI 1699987305 · SOUTHINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,669 in 37 payments from 5 companies in 2025. Trend: 2023 $818 · 2024 $1,132 · 2025 $1,669
Food & beverage: $1,669
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $808 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $367 |
| Axsome Therapeutics, Inc. | 2 | $242 |
| Neurocrine BioSciences, Inc. | 1 | $127 |
| Vanda Pharmaceuticals Inc. | 1 | $125 |
Products named: VRAYLAR, CAPLYTA, Auvelity, INGREZZA, FANAPT.
Industry payments across CT — which companies pay providers there.
